🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, prospective, multicenter, open-label, Phase III clini...
Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Start Date
2024-07-29
Trial ID
NCT06507371
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested
Study on the therapeutic effect of different infusion times on tislelizumab...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
Start Date
2025-12-01
Trial ID
NCT07243691
Treatments Being Tested
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2021-01-01
Trial ID
NCT06333561
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This trial is an open, phase II clinical study. The study is divided into t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-09-30
Trial ID
NCT05775874
Treatments Being Tested
This is a prospective, open-label, single-center clinical study, to evaluat...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2022-02-24
Trial ID
NCT05254847
Treatments Being Tested
This study is a single-center, prospective, open-label, randomized controll...
Status
Completed
Location
Fourth Hospital of Hebei Medical University
Start Date
2021-09-01
Trial ID
NCT05086627
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-04-01
Trial ID
NCT07531979
Treatments Being Tested